Delivery Order SPE2DB20D7066-SPE2DB24FC2DN
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Advair HFA 115-21 mcg inhalers. The $25,074.96 firm fixed-price delivery order contract has a completion date of May 6, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- This federal contract award is a $11,441.79 firm fixed price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of Advair HFA 115-21 mcg inhalers, to be completed by February 16, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor providing a range of pharmaceutical products and medical supplies to U.S. government agencies, particularly...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $2,061.14 firm fixed price delivery order is for the provision of Advair HFA 115-21 mcg inhalers. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,292.40 firm fixed price delivery order is for the supply of Advair HFA 115-21 MCG Inhaler, 12GM to support military treatment programs and facilities. Amerisourcebergen Drug Corp, as a prime contractor, has an extensive history of providing pharmaceutical products, medical supplies, and distribution services to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) for the delivery of Advair HFA 230-21 MCG inhalers. The firm-fixed-price delivery order, valued at $15,070.88, has an ultimate completion date of April 3, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $15,268.32 firm fixed price delivery order is for the provision of Advair HFA 115-21 MCG Inhaler 12GM, a pharmaceutical product. This delivery order falls under a larger $999,999,999.00 indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, which serves as the primary contract vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a for-profit subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $2,922.88 firm fixed price delivery order is for the supply of Advair HFA 230-21 MCG inhalers. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Advair HFA 115-21 mcg inhalers. The $12,265.08 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical for providing a comprehensive range of medical commodities to support military treatment programs and facilities...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $4,741.43 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of Advair HFA 45-21 MCG Inhaler 12GM. This is an order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999.00 through December 31, 2025. As a major supplier of pharmaceutical products and medical supplies to federal agencies,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company and subsidiary of Amerisourcebergen Corporation. The $14,745.04 firm fixed-price delivery order is for the supply of an Advair HFA 230-21 mcg inhaler product. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB24FC2DNDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of Advair HFA 115-21 MCG Inhalers. The $14,438.16 firm-fixed-price delivery order is not associated with a set-aside program. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. (doing business as Amerisourcebergen), is a major supplier of pharmaceuticals and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The company holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the DoD worldwide. This specific delivery order appears to be part of that larger IDC vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.4k | 5/13/24 |